Total entries:  4

DRACPC0003

Active Ingredients:  Octreotide

Type:  Biotech

Active Sequence:  FCFWKXCT

Molecular Formula: C49H66N10O10S2

DrugBank Accession Number:  DB00104

PubChem CID:  6400441

NCI Thesaurus Code:  C711  

Disease: Acromegaly, Diarrhea, Metastatic Carcinoid Tumors

DRACPC0005

Active Ingredients:  Lanreotide

Type:  Small Molecule

Active Sequence:  XCYWKVCX

Molecular Formula: C54H69N11O10S2

DrugBank Accession Number:  DB06791

PubChem CID:  6918011

NCI Thesaurus Code:  C1523  

Disease: Gastroenteropancreatic neuroendocrine tumors, Acromegaly

DRACPC0008

Active Ingredients:  Somatostatin

Type:  Small Molecule

Active Sequence:  AGCKNFFWKTFTSC

Molecular Formula: C76H104N18O19S2

DrugBank Accession Number:  DB09099

PubChem CID:  16129706

NCI Thesaurus Code:  C836  

Disease: Various tumours, Oesophageal varices haemorrhage, Gastritis haemorrhagic, Acromegaly

DRACPC0013

Active Ingredients:  Lutetium Lu 177 dotatate

Type:  Small Molecule

Active Sequence:  Not available

Molecular Formula: C65H87LuN14O19S2

DrugBank Accession Number:  DB13985

PubChem CID:  76966897

NCI Thesaurus Code:  C95020  

Disease: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

<< < 1 >>

DRACP is developed by Dr.Zheng's team.